Merck KGaA Chairman Karl-Ludwig Kley Says Industry Model Not Broken: An Interview With PharmAsia News (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Merck KGaA Global Chariman Karl-Ludwig Kley, while soft-spoken, is fiercely determined to make a lasting impact for stakeholders. Kley contradicts commonly expressed views within the pharma industrly on the challenges confronting the industry. At 60, Kley has gathered vast experience across industries having worked at Siemens AG before moving into the pharmaceutical industry with a job at Bayer AG back in 1982. In 2006, Kley joined Merck and a year later he was appointed as its Chairman. On his recent visit to India, he spoke to PharmAsia News' India Bureau on a range of subjects related to the global industry and the shape of emerging markets in coming years.